HS6ST2 enzyme an important regulator of breast cancer cell-bone interactions

[News]

Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.

More... (http://www.news-medical.net/news/20120521/HS6ST2-enzyme-an-important-regulator-of-breast-cancer-cell-bone-interactions.aspx)